Adage Capital Partners’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.49M Sell
2025
Q2
$1.93M Sell
2025
Q1
$8.86M Sell
2024
Q4
$14.6M Sell
2024
Q3
$20.4M Sell
2024
Q2
$19.6M Buy